Navigation Links
Watchdog to Be Set on Oral Chemotherapy, Warns Experts

A survey conducted by Dana-Farber Cancer Institute in Boston, Massachusetts has come out with findings that oral chemotherapy drugs need to be monitored, prescribed and// coordinated in a better way.

Listing cases of unfortunate events, sourced from the institutes that participated in the research, Dr Lawrence Shulman, of the Dana-Farber Cancer Institute, said findings underline the importance of forging a consensus in the oncology field on standardized safeguards and practices for prescribing and monitoring the use of these drugs.

Many centers had no formal system for monitoring patients taking the drugs, which are becoming increasingly popular internationally.

"Given how quickly oral chemotherapies have become standard care for a growing number of cancers, we were not surprised to find variations in how organizations prescribe and monitor the use of these agents," said Dr Saul Weingart, the president of patient safety at Dana-Farber.

An example was that on prescriptions for the six most common oral chemotherapies: Only 26 percent of the centers required a patient's diagnosis; only 9 percent required a patient's treatment schedule and length of treatment; and only 9 percent required a patient's body surface area calculation, which is used to determine correct and safe drug dose.

The researchers found that almost 70 percent of the centers used handwritten orders for most of the oral chemotherapy prescriptions, 5 percent used preprinted paper prescriptions, and 14 percent used computer-based prescription order entry systems.

Yet another expert thinks that cancer centers need to treat oral chemotherapy drugs in the same way they treat intravenous ones.

"We can't assume that because a drug is an oral drug it is going to be properly prescribed, properly dispensed and properly confirmed that the patient has taken it," said Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Societ y. "This study raises the question whether we, as doctors, need to be more vigilant."
ANN
'"/>




Related medicine news :

1. Pets As Disease Watchdogs
2. Health Watchdog Advises a Rethink on NHS Cancer Services
3. Carcinogens in Fish Worries Chinese Watchdogs
4. Drugs Watchdog Faces A Judicial Review
5. Radiation And Chemotherapy, A Better Option For Head And Neck Cancer
6. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
7. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
8. ADB Report Warns of Bird-Flu Catastrophe
9. FDA Warns Against Birth-Control Patch
10. Charlotte Church Warns kiss n tell girls not to flirt with Henson
11. UK Committee Warns on Food Shortages Due to Flu Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and ... and financial preparation services, is providing an update on a charitable event that ... City Rescue is a locally recognized nonprofit that provides shelter and care for ...
(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: